NUCB2 and renal cell carcinoma: In vivo and in vitro studies revealed the role of nesfatin-1 in cancer progression, particularly in the process of the development and invasion in RCC by increased EMT through the AMPK/TORC1/ZEB1 signalling pathway [35,36].